Filing
Spy
Filing
Spy
Home
About
FNCH
Finch Therapeutics Group Inc
Clinical-stage biotechnology company developing microbiome therapies
CUSIP: 31773D101
Healthcare
US
1 holder
Ownership
Activity
2022 Q2
4 of 9 quarters
Total Value
$3.19M
Total Shares
1.12M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$3.19M
1.12M
0.0%
Unchanged
Baupost Group LLC
$3.19M
1.12M shares
Unchanged
FNCH — Finch Therapeutics Group Inc - FilingSpy